Intratumor heterogeneity: the rosetta stone of therapy resistance

A Marusyk, M Janiszewska, K Polyak - Cancer cell, 2020 - cell.com
Advances in our understanding of molecular mechanisms of tumorigenesis have translated
into knowledge-based therapies directed against specific oncogenic signaling targets …

Systems biology of cancer metastasis

Y Suhail, MP Cain, K Vanaja, PA Kurywchak… - Cell systems, 2019 - cell.com
Cancer metastasis is no longer viewed as a linear cascade of events but rather as a series
of concurrent, partially overlap** processes, as successfully metastasizing cells assume …

Tumour acidosis: from the passenger to the driver's seat

C Corbet, O Feron - Nature Reviews Cancer, 2017 - nature.com
The high metabolic demand of cancer cells leads to an accumulation of H+ ions in the
tumour microenvironment. The disorganized tumour vasculature prevents an efficient wash …

Phenotypic plasticity and genetic control in colorectal cancer evolution

J Househam, T Heide, GD Cresswell, I Spiteri… - Nature, 2022 - nature.com
Genetic and epigenetic variation, together with transcriptional plasticity, contribute to
intratumour heterogeneity. The interplay of these biological processes and their respective …

The enhancement of glycolysis regulates pancreatic cancer metastasis

J Yang, B Ren, G Yang, H Wang, G Chen, L You… - Cellular and Molecular …, 2020 - Springer
Pancreatic ductal adenocarcinoma is prone to distant metastasis and is expected to become
the second leading cause of cancer-related death. In an extremely nutrient-deficient and …

Pancreatic cancer biology and genetics from an evolutionary perspective

A Makohon-Moore, CA Iacobuzio-Donahue - Nature Reviews Cancer, 2016 - nature.com
Cancer is an evolutionary disease, containing the hallmarks of an asexually reproducing
unicellular organism subject to evolutionary paradigms. Pancreatic ductal adenocarcinoma …

Metabolic reprogramming of cancer cells during tumor progression and metastasis

K Ohshima, E Morii - Metabolites, 2021 - mdpi.com
Cancer cells face various metabolic challenges during tumor progression, including growth
in the nutrient-altered and oxygen-deficient microenvironment of the primary site …

Changes in CT radiomic features associated with lymphocyte distribution predict overall survival and response to immunotherapy in non–small cell lung cancer

M Khorrami, P Prasanna, A Gupta, P Patil… - Cancer immunology …, 2020 - aacrjournals.org
No predictive biomarkers can robustly identify patients with non–small cell lung cancer
(NSCLC) who will benefit from immune checkpoint inhibitor (ICI) therapies. Here, in a …

Fatty acid synthase (FASN) as a therapeutic target in breast cancer

JA Menendez, R Lupu - Expert opinion on therapeutic targets, 2017 - Taylor & Francis
Introduction: Ten years ago, we put forward the metabolo-oncogenic nature of fatty acid
synthase (FASN) in breast cancer. Since the conception of this hypothesis, which provided a …

The 2019 mathematical oncology roadmap

RC Rockne, A Hawkins-Daarud, KR Swanson… - Physical …, 2019 - iopscience.iop.org
Whether the nom de guerre is Mathematical Oncology, Computational or Systems Biology,
Theoretical Biology, Evolutionary Oncology, Bioinformatics, or simply Basic Science, there is …